🇺🇸 FDA
Pipeline program

BETAMETHASONE, Placebo of fludrocortisone, HYDROCORTISONE HEMISUCCINATE, Placebo of hydrocortisone, FLUDROCORTISONE

APHP191110

Phase 3 small_molecule active

Quick answer

BETAMETHASONE, Placebo of fludrocortisone, HYDROCORTISONE HEMISUCCINATE, Placebo of hydrocortisone, FLUDROCORTISONE for Patients admitted to the ICU proven or suspected infection as the main diagnosis. is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Patients admitted to the ICU proven or suspected infection as the main diagnosis.
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials